These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7675968)

  • 1. Scopolamine and lorazepam exert different patterns of effects in a test battery assessing stages of information processing.
    Duka T; Redemann B; Voet B
    Psychopharmacology (Berl); 1995 Jun; 119(3):315-24. PubMed ID: 7675968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
    Curran HV; Schifano F; Lader M
    Psychopharmacology (Berl); 1991; 103(1):83-90. PubMed ID: 2006245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on word valence ratings, priming and recall.
    Schifano F; Curran HV
    Psychopharmacology (Berl); 1994 Jul; 115(3):430-4. PubMed ID: 7871085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.
    Kamboj SK; Curran HV
    Psychopharmacology (Berl); 2006 Nov; 188(4):482-8. PubMed ID: 17047934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.
    Mintzer MZ; Griffiths RR
    Cogn Affect Behav Neurosci; 2007 Jun; 7(2):120-9. PubMed ID: 17672383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lorazepam on memory, attention and sedation in man.
    Preston GC; Broks P; Traub M; Ward C; Poppleton P; Stahl SM
    Psychopharmacology (Berl); 1988; 95(2):208-15. PubMed ID: 3137599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine.
    Curran HV; Pooviboonsuk P; Dalton JA; Lader MH
    Psychopharmacology (Berl); 1998 Jan; 135(1):27-36. PubMed ID: 9489931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind parallel group placebo controlled comparison of sedative and mnesic effects of etifoxine and lorazepam in healthy subjects [corrected].
    Micallef J; Soubrouillard C; Guet F; Le Guern ME; Alquier C; Bruguerolle B; Blin O
    Fundam Clin Pharmacol; 2001 Jun; 15(3):209-16. PubMed ID: 11468032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sedation and memory: studies with a histamine H-1 receptor antagonist.
    Turner C; Handford AD; Nicholson AN
    J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming.
    Bishop KI; Curran HV
    Psychopharmacology (Berl); 1998 Dec; 140(3):345-53. PubMed ID: 9877014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study.
    Thiel CM; Henson RN; Dolan RJ
    Neuropsychopharmacology; 2002 Aug; 27(2):282-92. PubMed ID: 12093602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of scopolamine on matching to sample paradigm and related tests in human subjects.
    Koller G; Satzger W; Adam M; Wagner M; Kathmann N; Soyka M; Engel R
    Neuropsychobiology; 2003; 48(2):87-94. PubMed ID: 14504417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lorazepam on deductive reasoning.
    Pompéia S; Manzano GM; Pradella-Hallinan M; Bueno OF
    Psychopharmacology (Berl); 2007 Nov; 194(4):527-36. PubMed ID: 17622517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of scopolamine, diazepam, and lorazepam on working memory in pigeons: an analysis of reinforcement procedures and sample problem type.
    Savage LM; Stanchfield MA; Overmier JB
    Pharmacol Biochem Behav; 1994 May; 48(1):183-91. PubMed ID: 8029290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of lorazepam and oxazepam on priming.
    Curran HV; Gorenstein C
    Int Clin Psychopharmacol; 1993; 8(1):37-42. PubMed ID: 8473719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing between attentional and amnestic effects in information processing: the separate and combined effects of scopolamine and nicotine on verbal free recall.
    Rusted J; Eaton-Williams P
    Psychopharmacology (Berl); 1991; 104(3):363-6. PubMed ID: 1924643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorazepam induces multiple disturbances in selective attention: attentional overload, decrement in target processing efficiency, and shifts in perceptual discrimination and response bias.
    Michael GA; Bacon E; Offerlin-Meyer I
    J Psychopharmacol; 2007 Sep; 21(7):691-9. PubMed ID: 17259205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytics and memory: a comparison of lorazepam and alprazolam.
    Kumar R; Mac DS; Gabrielli WF; Goodwin DW
    J Clin Psychiatry; 1987 Apr; 48(4):158-60. PubMed ID: 3558328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.